Contract facts
FederalNo full NAICS 621112 intel page yet. Browse NAICS intelligence
SATELLITE PHARMACY OPTION 2 EXERCISE AND FUNDING is a federal award for Fa5613 700 Cons Pk held by Sterling Medical Associates, Inc. Estimated value $5.6M ($3.5M obligated). Current period of performance ends Mar 25, 2024.
SATELLITE PHARMACY OPTION 2 EXERCISE AND FUNDING
Recompete timing
PublicCurrent PoP ended Mar 25, 2024 (879 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordSterling Medical Associates, Inc — $115.4M obligated across 177 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract FA561319FA342?
FA561319FA342 (Satellite pharmacy OPTION 2 exercise and funding) is a Fa5613 700 Cons Pk award with a potential value of $5.6M, currently held by Sterling Medical Associates, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded FA561319FA342?
Fa5613 700 Cons Pk awarded FA561319FA342 to Sterling Medical Associates, Inc (potential $5.6M).
Who is the incumbent on FA561319FA342?
Sterling Medical Associates, Inc is the incumbent with $115.4M across 177 related awards in SCOUT’s public footprint. The current period of performance ends Mar 25, 2024.
When does Sterling Medical Associates, Inc’s FA561319FA342 come up for recompete?
SCOUT tracks a period-of-performance end of Mar 25, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
